NCT03109847 2025-12-11Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid CancersThomas Jefferson UniversityPhase 2 Terminated13 enrolled 8 charts
NCT05059470 2025-07-08IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATCM.D. Anderson Cancer CenterPhase 2 Terminated6 enrolled